FindMyKOL

Sudhaker Rao, MD

Basic profile

Henry Ford Health

ORCIDOn fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionDetroit, MI · MidwestSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
Active KOLFindMyKOL type: RegionalLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding1994–2016Why? →

Sudhaker Rao is an Endocrinology/Metabolic physician affiliated with Henry Ford Health. OpenAlex indexes 126 publications with 3,539 citations (h-index 25); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
126publications

Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.

3,539citations

Citations across these publications.

25h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 1994–2016

Federally funded research awards.

View funding ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Neurocrine BioSciences, Inc.
    Program year20251 payment
    $136
  • Radius Health, Inc.
    Program year20241 payment
    $62
  • Ascendis Pharma Inc
    Program year20232 payments
    $228
All 11 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    28.5%
    l-Thyroxine11.5%
    Levothyroxine Sodium100%
    Part D<11 patients
    Parathyroid Hormone-Related Peptide Analog7.6%
    Tymlos100%
    Part D<11 patients

    + 2 more classes in this area

  • Genitourinary & hormones

    22.2%
    Estrogen Agonist/Antagonist16%
    Raloxifene Hcl100%
    Part D≥14 patients
    Androgens and estrogens6.2%
    Premarin100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    20.5%
    Vitamin D3 Analog8.3%
    Calcitriol100%
    Part D<11 patients
    Provitamin D2 Compound6.6%
    Vitamin D2100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

2 NIH research awards on record, funded 1994–2016 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”